Application 079060
- Type
- ANDA
- Sponsor
- AUROBINDO PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ALFUZOSIN HYDROCHLORIDE | ALFUZOSIN HYDROCHLORIDE | TABLET, EXTENDED RELEASE;ORAL | 10MG | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 57237-114 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-114 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 57237-114 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Rising Health, LLC | ANDA | Current |
| 65862-249 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-249 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-249 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |
| 65862-249 | Alfuzosin Hydrochloride | Alfuzosin Hydrochloride | Aurobindo Pharma Limited | ANDA | Current |